Sector
PharmaceuticalsOpen
₹49.1Prev. Close
₹49Turnover(Lac.)
₹1,440.54Day's High
₹50Day's Low
₹39.252 Week's High
₹79.8352 Week's Low
₹35.67Book Value
₹7.53Face Value
₹2Mkt Cap (₹ Cr.)
329.94P/E
32.84EPS
1.22Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 16.6 | 16.6 | 16.6 | 4.15 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 35.77 | 27.25 | 19.98 | 28.31 |
Net Worth | 52.37 | 43.85 | 36.58 | 32.46 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Revenue | 122.38 | 88.63 | 97.68 | 61.02 |
yoy growth (%) | 38.07 | -9.26 | 60.07 | 12.14 |
Raw materials | -92.18 | -67.18 | -79.51 | -43.49 |
As % of sales | 75.32 | 75.79 | 81.39 | 71.27 |
Employee costs | -4.5 | -3.82 | -3.32 | -3.89 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 3.68 | 2.21 | 2.17 | 1.87 |
Depreciation | -1.65 | -1.66 | -1.51 | -1 |
Tax paid | -1.09 | -0.58 | -0.6 | -0.65 |
Working capital | 4.23 | 0.44 | -0.99 | 0.33 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 38.07 | -9.26 | 60.07 | 12.14 |
Op profit growth | 84.04 | 2.82 | -20.63 | -13.15 |
EBIT growth | 40.72 | 3.84 | -6.98 | 2.24 |
Net profit growth | 58.96 | 3.83 | 28.67 | -25.05 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Wholetime Director
Haresh Mehta
Managing Director
Harshit Mehta
Non Executive Director
Rita Mehta
Whole-time Director
Rishit Mehta
Independent Director
Deepak Vekaria
Independent Director
Bharat Rathod
Independent Director
Deepesh Shah
Independent Director
Anuj Mody
Independent Director
Kunal Vora
1105/1106 11-Flr Hubtown Solar,
N S Phadke Marg Andheri East,
Maharashtra - 400069
Tel: 91-22-2670 1055/66
Website: http://www.medicoremedies.com
Email: [email protected]
Subramanian Building,
1ST Floor No 1, Club House Road,
Chennai - 600002
Tel: 91-44-28462700
Website: www.cameoindia.com
Email: [email protected]
Summary
Medico Remedies Limited was incorporated as a Private Limited Company with the name Medico Remedies Private Limited on March 18, 1994. The status was changed to a Public Limited Company and the Compan...
Read More
Reports by Medico Remedies Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.